Prolene suture gonioscopy-assisted transluminal trabeculotomy safe and effective treatment of glaucoma: Study
Researchers found that prolene suture gonioscopy-assisted transluminal trabeculotomy (GATT) is efficient in reducing intraocular pressure (IOP) and diminishing the long-term usage of glaucoma medication. A recent study was published in the Journal of Glaucoma conducted by Zhang and colleagues.
The objective of the study was to evaluate the long-term effectiveness of prolene suture GATT in reducing IOP, and in minimizing the use of glaucoma medications, while identifying the risk factors for surgical outcomes. This was a retrospective cohort study of adult patients undergoing prolene suture GATT by a single surgeon at a medical center. Data from 145 eyes of 124 patients were analyzed concerning changes in intraocular pressure, use of glaucoma medications, and rates of reoperation up to four years of follow-up.
The study showed a marked reduction of IOP from a preoperative level of 22.1±7.8 mm Hg to 15.1±3.2 mm Hg at three years and 15.1±3.5 mm Hg at four years after the surgery.
• The number of medications for glaucoma was also reduced. It came down to 1.3 ± 1.4 at three years and 1.4 ± 1.5 at four years post surgery from the baseline of 3.2 ± 1.1 preoperatively. What was impressive was that 44% of the eyes were totally medication-free at year four.
• Those who had GATT alone tended to have a higher revision rate of 31% compared with those who had GATT/CE combined.
• Patients with prior trabeculoplasty had worse outcomes with a higher reoperation rate at 28.8% compared to those without trabeculoplasty, which stood at 16.1%.
• Kaplan–Meier survival analysis of combined GATT/CE surgery not combined with trabeculoplasty achieved the best outcome, with a median time to failure of 48 months.
• Contrastively, eyes that received GATT and previous trabeculoplasty exhibited a relatively short median time to failure of only 18 months. Eyes that had GATT alone, with or without prior trabeculoplasty, exhibited median times to failure of 9 and 12 months, respectively.
Prolene suture GATT effectively lowers intraocular pressure and reduces the use of medication for glaucoma during long-term follow-up, with many patients remaining medication-free years after surgery. These findings suggest that GATT is indeed a good option for the treatment of glaucoma.
Reference:
Zhang, X., Chow, A., & Chen, E. (2024). Surgery outcomes of prolene suture gonioscopy-assisted transluminal trabeculotomy (GATT): Up to 4 years follow-up and prognostic factors. Journal of Glaucoma, 33(9), 645–651. https://doi.org/10.1097/ijg.0000000000002417
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.